Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peach

Showing results (891-900 of 933) with videos related to

Pageof 94
Sort By:
Gastroenterology|November 6, 2018
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic EsophagitisIkuo Hirano, Margaret H Collins, Yehudith Assouline-Dayan, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2025
Nanomedicines targeting protease-activated receptor 2 in endosomes provide sustained analgesiaShavonne L Teng, Rocco Latorre, Divya Bhansali, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Blood|January 2, 2026
Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib SensitivityChloe Al Thompson-Peach, Daniel Thomas, Mara Dottore, et al.
Journal of Medical Ethics|September 19, 2013
Position statement on ethics, equipoise and research on charged particle radiation therapyMark Sheehan, Claire Timlin, Ken Peach, et al.
Nature Communications|September 25, 2025
Targeting prostaglandin E<sub>2</sub> receptor 2 in Schwann cells inhibits inflammatory pain but not inflammationRomina Nassini, Lorenzo Landini, Matilde Marini, et al.
The Medical Journal of Australia|May 28, 2024
Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional studyMadeleine J Marsland, Tilda N Thomson, Helen M O'Brien, et al.
Cureus|September 24, 2020
Does Point of Care Ultrasound Improve Resuscitation Markers in Undifferentiated Hypotension? An International Randomized Controlled Trial From The Sonography in Hypotension and Cardiac Arrest in the Emergency Department (SHoC-ED) SeriesPaul Atkinson, Luke Taylor, James Milne, et al.
Annals of Emergency Medicine|June 6, 2018
Does Point-of-Care Ultrasonography Improve Clinical Outcomes in Emergency Department Patients With Undifferentiated Hypotension? An International Randomized Controlled Trial From the SHoC-ED InvestigatorsPaul R Atkinson, James Milne, Laura Diegelmann, et al.
Pageof 94

Showing results (891-900 of 933) with videos related to

Sort By:
Pageof 94
Gastroenterology|November 6, 2018
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic EsophagitisIkuo Hirano, Margaret H Collins, Yehudith Assouline-Dayan, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2025
Nanomedicines targeting protease-activated receptor 2 in endosomes provide sustained analgesiaShavonne L Teng, Rocco Latorre, Divya Bhansali, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Blood|January 2, 2026
Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib SensitivityChloe Al Thompson-Peach, Daniel Thomas, Mara Dottore, et al.
Journal of Medical Ethics|September 19, 2013
Position statement on ethics, equipoise and research on charged particle radiation therapyMark Sheehan, Claire Timlin, Ken Peach, et al.
Nature Communications|September 25, 2025
Targeting prostaglandin E<sub>2</sub> receptor 2 in Schwann cells inhibits inflammatory pain but not inflammationRomina Nassini, Lorenzo Landini, Matilde Marini, et al.
The Medical Journal of Australia|May 28, 2024
Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional studyMadeleine J Marsland, Tilda N Thomson, Helen M O'Brien, et al.
Cureus|September 24, 2020
Does Point of Care Ultrasound Improve Resuscitation Markers in Undifferentiated Hypotension? An International Randomized Controlled Trial From The Sonography in Hypotension and Cardiac Arrest in the Emergency Department (SHoC-ED) SeriesPaul Atkinson, Luke Taylor, James Milne, et al.
Annals of Emergency Medicine|June 6, 2018
Does Point-of-Care Ultrasonography Improve Clinical Outcomes in Emergency Department Patients With Undifferentiated Hypotension? An International Randomized Controlled Trial From the SHoC-ED InvestigatorsPaul R Atkinson, James Milne, Laura Diegelmann, et al.
Pageof 94